Skip to main content


Buy Article:

$44.00 plus tax (Refund Policy)

Denmark is one of the stronger OECD members on a number of science and innovation indicators. It has a modern open market economy featuring a hightechnology agricultural sector and a sophisticated manufacturing industry, with world leaders in pharmaceuticals, maritime shipping and renewable energy. It has a large government R&D budget and high expenditure on biotechnology and pharmaceutical R&D. In 2008, Denmark's gross domestic expenditure on R&D (GERD) was 2.7% of GDP, firmly above the OECD average of 2.3%. Industry‐financed GERD increased to 61%, while government‐funded GERD declined to 25%. Business expenditure on R&D (BERD) was a comparatively high 1.9% of GDP in 2008; as a percentage of industry value added, this was almost double the OECD average. In that year, Denmark also had a high venture capital intensity of 0.16%, well above the average.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Document Type: Review Article

Publication date: 2010-12-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more